Conversely, a decreasing trend was observed in the use of TRBV5‐5, TRBV5‐8, TRBV6‐4, TRBV6‐5, and TRBV10‐1 genes in the HD, CBD, and CRC groups and of TRBV3‐1, TRBV4‐1, TRBV5‐6, TRBV5‐8, TRBV7‐4, TRBV10‐1, TRBV10‐2, TRBV12‐5, TRBV24‐1, TRBV27, and TRBV28 in the HD, BNC, and NSCLC groups.
← all excerpts
Peripheral Blood T-Cell Receptor Repertoire Diversity as a Potential Biomarker in the Diagnosis and Treatment Evaluation of Colorectal and Lung Cancers: A Prospective Observational Study.
1
—
—